News
This biosimilars market report focuses on rising market complexity and recent activity, including two new approvals and four ...
A national preexposure prophylaxis (PrEP) program would streamline access and improve HIV outcomes but unfortunately never came to pass because of a lack of funding, according to Jeremiah Johnson, ...
Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key role in the inflammatory response in plaque psoriasis.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...
A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...
Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...
H. pylori infection significantly contributes to stomach cancer risk, but effective screening and treatment can prevent ...
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...
Switching to extended half-life therapies for hemophilia enhances treatment adherence and reduces infusion frequency, despite ...
Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results